Quotient Sciences vs 重庆兴泰濠制药有限公司 (Sintaho)
Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.
Markdown mirror: /api/markdown/compare/quotientsciences/sintaho
| Category | Quotient Sciences | 重庆兴泰濠制药有限公司 (Sintaho) |
|---|---|---|
| Listed site | cdmo | cdmo |
| Summary | Integrated CDMO offering drug product formulation and manufacturing for small molecules and synthetic peptides, with 30+ years of experience and scalable capacity from clinical to 500 kg commercial batches across US and UK facilities. | China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries. |
| Services |
|
|
| Modalities |
|
|
| Indications | Data not yet provided. | Data not yet provided. |
| Locations |
|
|
| Certifications |
|
|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |